ARCHIVES

Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials

This article is from The Cancer Letter archive.

Vol. 29 No. 28 | July 11, 2003

Download PDF Visit The Full Archive

Related Articles

European regulators plan more rigorous rules for accelerated approval in cancer.

November 11, 2005

As Zeneca Buys Salick, Implications For Oncology Managed Care Uncertain

April 4, 1997

Institute Of Medicine Report Says Insurers Should Pay Patient Care Costs In Clinical Trials

February 24, 1989

IPRI’s Peter Boyle on Closing the Gap In Global Cancer Treatment And Outcomes

January 31, 2014

In Brief: ASTRO Elects New Officers; ASSIST Coordinators Express Concern Over NCI Plan To Cut Budget

November 27, 1992

MIT Researcher Ingested P-32; NRC Investigating

October 27, 1995